Heart scan breakthrough could end guesswork for AFib medication
NCT ID NCT05084495
Summary
This study aimed to find better ways to predict if a medication called flecainide will work for people with atrial fibrillation (AFib), a common irregular heartbeat. Researchers followed 50 patients for a year, using detailed heart scans and ECG tests to see if they could identify who would stay in normal rhythm and who might have side effects. The goal is to move away from the current 'trial-and-error' approach to prescribing this drug.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Sciences, Helsingborg Medical Faculty Lund University
Helsingborg, Skåne County, 25187, Sweden
Conditions
Explore the condition pages connected to this study.